News

Chips JU call for Design Platform

Published on | 5 months ago

Programmes Digital, Industry & Space Semiconductors

The Chips Joint Undertaking has opened a new call for proposal for a Design Platform (DIGITAL-Chips-2024-CSA-CDP-1).

This call concerns the selection of the consortium in charge of the overall coordination of the Design Platform, referred to as the Platform Coordination Team (PCT), which shall serve as the hosting entity for the Design Platform’s virtual infrastructure and central services, coordinating access to a wide range of tools, assets and services.

The chosen implementation model foresees a central consortium, referred to as the Platform Coordination Team (PCT) that operates the overall Design Platform initiative, serves as the hosting entity of the central cloud infrastructure and manages the development of its users. The PCT shall assist the Chips Joint Undertaking (Chips JU) in defining the technical specifications of the cloud service for the platform to be procured by the Chips JU through a dedicated Call for Tenders.

This call is interlinked with call DIGITAL-Chips-2024-CfEoI -CDP-1, a Call for Expression of Interest (hereinafter “CfEoI”) for the selection of a Hosting Consortium, see the Chips JU website for more information.

Only proposals successful in both interrelated calls will be considered for funding.

More information on the call can be found on the Funding & Tenders Portal. The deadline to submit proposals is 10 October 2024.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1530 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.